• Fresenius posted Q1 2026 revenue of €5.74 billion, up 5% organically, while EBIT rose 6% to €678 million and margin widened 0.2 percentage point to 11.8%.
• Core EPS climbed 13% to €0.82, supported by lower net interest expense and a lower tax rate.
• Fresenius Kabi revenue rose 6% organically to €2.15 billion, while Helios increased 4% organically to €3.5 billion and lifted EBIT 10% to €368 million as efficiency gains and a billing surcharge in Germany boosted results.
• Operating cash flow rose to €389 million, more than quadrupling versus prior-year quarter, and leverage improved to 2.6x.
• CEO Michael Sen said Fresenius started 2026 “excellently” and confirmed full-year guidance for 4%-7% organic revenue growth and 5%-10% core EPS growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fresenius SE & Co. KGaA published the original content used to generate this news brief on May 06, 2026, and is solely responsible for the information contained therein.